Deals·October 22, 2026 at 9:27 AM EDT·1 source
Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push
LLY -2.5%OURA
LLY · last 30 trading days+0.2% since the news
News
What happened
- Mubadala Bio signed a deal with Eli Lilly to package and distribute GLP-1 drugs locally.
- The agreement was announced during Abu Dhabi’s Future Health Summit as part of a broader healthcare push involving Oura and Whoop.
Why it matters
The agreement signals Abu Dhabi’s effort to attract healthcare companies and build local pharmaceutical distribution capabilities. It may matter to healthcare investors and corporate-development professionals tracking GLP-1 commercialization and regional expansion.
Deal terms
raise
Mubadala Bio → Eli Lilly
Value
—
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
Timeline
- EarlierOct 19Here are Monday's biggest analyst calls: SpaceX, Nvidia, Apple, CoreWeave, Amazon, Meta, Eli Lilly & more
- EarlierOct 20STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole
- EarlierOct 21Lilly’s retatrutide creeps closer to market for sleep apnea
- First reported by SemaforOct 22Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare push
Who is involved
investing inAbu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare pushEli LillyLLY · targetMubadala BiobuyerOuraOURAWhoop
CompanyInvestorThe deal
Sources (1)
Related
- Yesterday · #ESMO26: AstraZeneca eyes Keytruda's Padcev spot; Lilly's ADC takes on Elahere; Nubeqa targets earlier prostate cancer
- Oct 19 · Here are Monday's biggest analyst calls: SpaceX, Nvidia, Apple, CoreWeave, Amazon, Meta, Eli Lilly & more
- Oct 23 · Oura sues rival Ultrahuman again, threatening its U.S. smart ring comeback
- Oct 22 · Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020
- Oct 21 · Lilly’s retatrutide creeps closer to market for sleep apnea
- Oct 20 · STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole
Read more on YouBank
The Newsroom, ranked for your desk
About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.
- Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
- Follow developing storiesAn alert, and a push, the moment a story you follow moves.
- Your briefing, read aloudA few minutes each morning with a chapter per story.
- Brief modeSwipe through the day, a 20-second card each.